Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children
Clinical trial NCT01506193 · COMPLETED
Trial details
- NCT number
- NCT01506193
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-06
- Primary completion
- 2014-02-17
- Enrollment
- 716
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.